Medicare mandates to reduce chemical restraints
On Wednesday, Medicare announced an initiative to reduce the use of antipsychotics drugs among dementia patients by 15 percent by the end of the year, using techniques like the one above. Federal officials said such drugs are dangerous for elderly patients with dementia—nearly doubling the risk of death —and are overused as a way to control difficult behaviors of nursing home patients. In fact, every two in five nursing home patients with dementia is given antipsychotics even though they have no diagnosed psychosis, said Dr. Sherry Ling, deputy chief of the Center for Medicare and Medicaid Services, during a telephone news conference on Wednesday.
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital
- 3 Traits Personality Assessments Can't Reveal
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- Half of All Primary Care, Internal Medicine Jobs Unfilled in 2013
- Carondelet to Pay $35M to Settle Fraud Allegations
- CHS Hacked, 4.5M Patient Records Compromised